Trial Profile

ENSAYO DE FASE IV-II, BRAZO UNICO, ABIERTO, CON IRINOTECAN EN COMBINACION CON CIS-PLATINO EN PACIENTES PEDIATRICOS CON GLIOMAS DE MAL PRONOSTICO. PHASE IV-II SINGLE-ARM, OPEN LABEL STUDY OF IRINOTECAN IN COMBINATION WITH CISPLATIN IN CHILDREN WITH GLIOMAS OF UNFAVORABLE PROGNOSIS.

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Aug 2015 Biomarkers information updated
15 Nov 2012 Planned End Date changed from 1 Sep 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
11 Apr 2012 New source identified and integrated (NCT01574092: ClinicalTrials.gov: US National Institutes of Health).

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com